Isolation of human CD4/CD8 double-positive, graft-versus-host disease-protective, minor histocompatibility antigen-specific regulatory T cells and of a novel HLA-DR7-restricted HY-specific CD4 clone

Journal of Immunology

Volumn 190, Issue 1, 2013, Pages 184-194

  Eljaafari, Assia ^a,b   Yuruker, Ozel ^c   Ferrand, Christophe ^a,d   Farre, Annie ^a   Addey, Caroline ^c   Tartelin, Marie Laure ^b   Thomas, Xavier ^e   Tiberghien, Pierre ^a   Simpson, Elizabeth ^c   Rigal, Dominique ^a   Scott, Diane ^c  

^a ETABLISSEMENT FRANÇAIS DU SANG   (France)

^b HOSPICES CIVILS DE LYON   (France)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d RIGHT Interactions Hôte Greffon Tumeur Ingénierie Cellulaire et Génique   (France)

^e CENTRE HOSPITALIER LYON SUD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; GAMMA INTERFERON; HLA ANTIGEN CLASS 1; HLA DR7 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; MINOR HISTOCOMPATIBILITY ANTIGEN;

ACUTE GRAFT VERSUS HOST DISEASE; ANTIGEN PRESENTING CELL; ARTICLE; BONE MARROW TRANSPLANTATION; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ISOLATION; CONTROLLED STUDY; CYTOFLUOROMETRY; CYTOTOXICITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN BIOPSY;

ANTIGEN PRESENTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE, TRANSFORMED; CELL SEPARATION; CLONE CELLS; EPITOPES, T-LYMPHOCYTE; FEMALE; GRAFT VS HOST DISEASE; H-Y ANTIGEN; HLA-DR7 ANTIGEN; HLA-DRB1 CHAINS; HUMANS; MALE; MINOR HISTOCOMPATIBILITY ANTIGENS; T-LYMPHOCYTES, REGULATORY;

EID: 84871848668     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201163     Document Type: Article

References (52)

1. Simpson, E., and D. Roopenian. 1997. Minor histocompatibility antigens. Curr. Opin. Immunol. 9: 655-661. (Pubitemid 27485293)
2. Hambach, L., and E. Goulmy. 2005. Immunotherapy of cancer through targeting of minor histocompatibility antigens. Curr. Opin. Immunol. 17: 202- 210.
3. Falkenburg, J. H., L. van de Corput, E. W. Marijt, and R. Willemze. 2003. Minor histocompatibility antigens in human stem cell transplantation. Exp. Hematol. 31: 743-751. (Pubitemid 37075966)
4. Marijt, W. A., M. H. Heemskerk, F. M. Kloosterboer, E. Goulmy, M. G. Kester, M. A. van der Hoorn, S. A. van Luxemburg-Heys, M. Hoogeboom, T. Mutis, J. W. Drijfhout, et al. 2003. Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia. Proc. Natl. Acad. Sci. USA 100: 2742-2747. (Pubitemid 36297569)
5. Advisory Committee of the International Bone Marrow Transplant Registry. 1989. Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 4: 221-228.
6. Vogt, M. H., J. W. van den Muijsenberg, E. Goulmy, E. Spierings, P. Kluck, M. G. Kester, R. A. van Soest, J. W. Drijfhout, R. Willemze, and J. H. Falkenburg. 2002. The DBY gene codes for an HLA-DQ5-restricted human male-specific minor histocompatibility antigen involved in graft-versus-host disease. Blood 99: 3027-3032. (Pubitemid 34525395)
7. Spierings, E., C. J. Vermeulen, M. H. Vogt, L. E. Doerner, J. H. Falkenburg, T. Mutis, and E. Goulmy. 2003. Identification of HLA class II-restricted H-Yspecific T-helper epitope evoking CD4+ T-helper cells in H-Y-mismatched transplantation. Lancet 362: 610-615. (Pubitemid 37013301)
8. Ferrara, J. L., J. E. Levine, P. Reddy, and E. Holler. 2009. Graft-versus-host disease. Lancet 373: 1550-1561.
9. Hambach, L., B. A. Nijmeijer, Z. Aghai, M. L. Schie, M. H. Wauben, J. H. Falkenburg, and E. Goulmy. 2006. Human cytotoxic T lymphocytes specific for a single minor histocompatibility antigen HA-1 are effective against human lymphoblastic leukaemia in NOD/scid mice. Leukemia 20: 371- 374.
10. Hambach, L., M. Vermeij, A. Buser, Z. Aghai, T. van der Kwast, and E. Goulmy. 2008. Targeting a single mismatched minor histocompatibility antigen with tumor-restricted expression eradicates human solid tumors. Blood 112: 1844- 1852.
11. Rutten, C. E., S. A. van Luxemburg-Heijs, M. Griffioen, E. W. Marijt, I. Jedema, M. H. Heemskerk, E. F. Posthuma, R. Willemze, and J. H. Falkenburg. 2008. HLA-DP as specific target for cellular immunotherapy in HLA class IIexpressing B-cell leukemia. Leukemia 22: 1387-1394. (Pubitemid 352006083)
12. Meyer, R. G., C. M. Britten, D. Wehler, K. Bender, G. Hess, A. Konur, U. F. Hartwig, T. C. Wehler, A. J. Ullmann, C. Gentilini, et al. 2007. Prophylactic transfer of CD8-depleted donor lymphocytes after T-cell-depleted reducedintensity transplantation. Blood 109: 374-382. (Pubitemid 46053080)
13. Kawase, T., Y. Nannya, H. Torikai, G. Yamamoto, M. Onizuka, S. Morishima, K. Tsujimura, K. Miyamura, Y. Kodera, Y. Morishima, et al. 2008. Identification of human minor histocompatibility antigens based on genetic association with highly parallel genotyping of pooled DNA. Blood 111: 3286-3294.
14. Kamei, M., Y. Nannya, H. Torikai, T. Kawase, K. Taura, Y. Inamoto, T. Takahashi, M. Yazaki, S. Morishima, K. Tsujimura, et al. 2009. HapMap scanning of novel human minor histocompatibility antigens. Blood 113: 5041- 5048.
15. Warren, E. H., N. J. Vigneron, M. A. Gavin, P. G. Coulie, V. Stroobant, A. Dalet, S. S. Tykodi, S. M. Xuereb, J. K. Mito, S. R. Riddell, and B. J. Van den Eynde. 2006. An antigen produced by splicing of noncontiguous peptides in the reverse order. Science 313: 1444-1447. (Pubitemid 44360274)
16. Murata, M., E. H. Warren, and S. R. Riddell. 2003. A human minor histocompatibility antigen resulting from differential expression due to a gene deletion. J. Exp. Med. 197: 1279-1289. (Pubitemid 36617774)
17. Van Bergen, C. A., C. E. Rutten, E. D. Van Der Meijden, S. A. Van Luxemburg-Heijs, E. G. Lurvink, J. J. Houwing-Duistermaat, M. G. Kester, A. Mulder, R. Willemze, J. H. Falkenburg, and M. Griffioen. 2010. High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning. Cancer Res. 70: 9073-9083.
18. Simpson, E., D. Scott, E. James, G. Lombardi, K. Cwynarski, F. Dazzi, M. Millrain, and P. J. Dyson. 2002. Minor H antigens: genes and peptides. Transpl. Immunol. 10: 115-123.
19. Laurin, D., E. Spierings, L. T. van der Veken, A. Hamrouni, J. H. Falkenburg, G. Souillet, C. Vermeulen, A. Farre, C. Galambrun, D. Rigal, et al. 2006. Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro. Biol. Blood Marrow Transplant. 12: 1114-1124. (Pubitemid 44667877)
20. Stumpf, A. N., E. D. van der Meijden, C. A. van Bergen, R. Willemze, J. H. Falkenburg, and M. Griffioen. 2009. Identification of 4 new HLA-DRrestricted minor histocompatibility antigens as hematopoietic targets in antitumor immunity. Blood 114: 3684-3692.
21. van de Corput, L., P. Chaux, E. D. van der Meijden, E. De Plaen, J. H. Frederik Falkenburg, and P. van der Bruggen. 2005. A novel approach to identify antigens recognized by CD4 T cells using complement-opsonized bacteria expressing a cDNA library. Leukemia 19: 279-285. (Pubitemid 40220594)
22. Griffioen, M., E. D. van der Meijden, E. H. Slager, M. W. Honders, C. E. Rutten, S. A. van Luxemburg-Heijs, P. A. von dem Borne, J. J. van Rood, R. Willemze, and J. H. Falkenburg. 2008. Identification of phosphatidylinositol 4-kinase type II beta as HLA class II-restricted target in graft versus leukemia reactivity. Proc. Natl. Acad. Sci. USA 105: 3837-3842. (Pubitemid 351723486)
23. Spaapen, R. M., H. M. Lokhorst, K. van den Oudenalder, B. E. Otterud, H. Dolstra, M. F. Leppert, M. C. Minnema, A. C. Bloem, and T. Mutis. 2008. Toward targeting B cell cancers with CD4+ CTLs: identification of a CD19- encoded minor histocompatibility antigen using a novel genome-wide analysis. J. Exp. Med. 205: 2863-2872.
24. Reinsmoen, N. L., J. H. Kersey, and F. H. Bach. 1984. Detection of HLA restricted anti-minor histocompatibility antigen(s) reactive cells from skin GVHD lesions. Hum. Immunol. 11: 249-257. (Pubitemid 15186354)
25. Maile, R., S. M. Pop, R. Tisch, E. J. Collins, B. A. Cairns, and J. A. Frelinger. 2006. Low-avidity CD8lo T cells induced by incomplete antigen stimulation in vivo regulate naive higher avidity CD8hi T cell responses to the same antigen. Eur. J. Immunol. 36: 397-410. (Pubitemid 43257463)
26. Burlingham, W. J., and E. Goulmy. 2008. Human CD8+ T-regulatory cells with low-avidity T-cell receptor specific for minor histocompatibility antigens. Hum. Immunol. 69: 728-731.
27. Eljaafari, A., A. Farre, K. Duperrier, J. Even, H. Vie, M. Michallet, G. Souillet, A. Catherine Freidel, L. Gebuhrer, and D. Rigal. 2001. Generation of helper and cytotoxic CD4+T cell clones specific for the minor histocompatibility antigen HY, after in vitro priming of human T cells by HLA-identical monocyte-derived dendritic cells. Transplantation 71: 1449-1455. (Pubitemid 32507120)
28. Kinsella, T. M., and G. P. Nolan. 1996. Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum. Gene Ther. 7: 1405-1413. (Pubitemid 26293560)
29. Parel, Y., and C. Chizzolini. 2004. CD4+ CD8+ double positive (DP) T cells in health and disease. Autoimmun. Rev. 3: 215-220. (Pubitemid 38521097)
30. Calado, R. T., A. B. Garcia, and R. P. Falcão. 1999. Age-related changes of immunophenotypically immature lymphocytes in normal human peripheral blood. Cytometry 38: 133-137.
31. Ortolani, C., E. Forti, E. Radin, R. Cibin, and A. Cossarizza. 1993. Cytofluorimetric identification of two populations of double positive (CD4+,CD8+) T lymphocytes in human peripheral blood. Biochem. Biophys. Res. Commun. 191: 601-609. (Pubitemid 23222678)
32. Munschauer, F. E., C. Stewart, L. Jacobs, S. Kaba, Z. Ghorishi, S. J. Greenberg, and D. Cookfair. 1993. Circulating CD3+ CD4+ CD8+ T lymphocytes in multiple sclerosis. J. Clin. Immunol. 13: 113-118. (Pubitemid 23096256)
33. Parel, Y., M. Aurrand-Lions, A. Scheja, J. M. Dayer, E. Roosnek, and C. Chizzolini. 2007. Presence of CD4+CD8+ double-positive T cells with very high interleukin-4 production potential in lesional skin of patients with systemic sclerosis. Arthritis Rheum. 56: 3459-3467. (Pubitemid 47585442)
34. Iwatani, Y., Y. Hidaka, F. Matsuzuka, K. Kuma, and N. Amino. 1993. Intrathyroidal lymphocyte subsets, including unusual CD4+ CD8+ cells and CD3loTCR alpha beta lo/-CD4-CD8- cells, in autoimmune thyroid disease. Clin. Exp. Immunol. 93: 430-436. (Pubitemid 23276271)
35. Hirao, J., and K. Sugita. 1998. Circulating CD4+CD8+ T lymphocytes in patients with Kawasaki disease. Clin. Exp. Immunol. 111: 397-401. (Pubitemid 28088324)
36. Rahemtullah, A., K. K. Reichard, F. I. Preffer, N. L. Harris, and R. P. Hasserjian. 2006. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am. J. Clin. Pathol. 126: 805-814. (Pubitemid 44707632)
37. Burdick, J. F., W. E. Beschorner, W. J. Smith, D. McGraw, W. L. Bender, G. M. Williams, and K. Solez. 1984. Characteristics of early routine renal allograft biopsies. Transplantation 38: 679-684. (Pubitemid 15183479)
38. Godden, U., J. Herbert, R. D. Stewart, and B. Roser. 1985. A novel cell type carrying both Th and Tc/s markers in the blood of cyclosporine-treated, allografted rats. Transplantation 39: 624-628. (Pubitemid 15066953)
39. Bagot, M., H. Echchakir, F. Mami-Chouaib, M. H. Delfau-Larue, D. Charue, A. Bernheim, S. Chouaib, L. Boumsell, and A. Bensussan. 1998. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 91: 4331-4341. (Pubitemid 28261998)
40. Nascimbeni, M., E. C. Shin, L. Chiriboga, D. E. Kleiner, and B. Rehermann. 2004. Peripheral CD4(+)CD8(+) T cells are differentiated effector memory cells with antiviral functions. Blood 104: 478-486. (Pubitemid 38900031)
41. Zloza, A., Y. B. Sullivan, E. Connick, A. L. Landay, and L. Al-Harthi. 2003. CD8+ T cells that express CD4 on their surface (CD4dimCD8bright T cells) recognize an antigen-specific target, are detected in vivo, and can be productively infected by T-tropic HIV. Blood 102: 2156-2164. (Pubitemid 37122393)
42. Weiss, L., A. Roux, S. Garcia, C. Demouchy, N. Haeffner-Cavaillon, M. D. Kazatchkine, and M. L. Gougeon. 1998. Persistent expansion, in a human immunodeficiency virus-infected person, of V beta-restricted CD4+CD8+ T lymphocytes that express cytotoxicity-associated molecules and are committed to produce interferon-gamma and tumor necrosis factor-alpha. J. Infect. Dis. 178: 1158-1162. (Pubitemid 28452214)
43. Desfrançois, J., L. Derré, M. Corvaisier, B. Le Mével, V. Catros, F. Jotereau, and N. Gervois. 2009. Increased frequency of nonconventional double positive CD4CD8 alphabeta T cells in human breast pleural effusions. Int. J. Cancer 125: 374-380.
44. Desfrançois, J., A. Moreau-Aubry, V. Vignard, Y. Godet, A. Khammari, B. Dréno, F. Jotereau, and N. Gervois. 2010. Double positive CD4CD8 alphabeta T cells: a new tumor-reactive population in human melanomas. PLoS ONE 5: e8437.
45. Das, G., M. M. Augustine, J. Das, K. Bottomly, P. Ray, and A. Ray. 2003. An important regulatory role for CD4+CD8 alpha alpha T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc. Natl. Acad. Sci. USA 100: 5324-5329. (Pubitemid 36542704)
46. Eljaafari, A., Y. P. Li, and P. Miossec. 2009. IFN-gamma, as secreted during an alloresponse, induces differentiation of monocytes into tolerogenic dendritic cells, resulting in FoxP3+ regulatory T cell promotion. J. Immunol. 183: 2932- 2945.
47. Sawitzki, B., C. I. Kingsley, V. Oliveira, M. Karim, M. Herber, and K. J. Wood. 2005. IFN-gamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J. Exp. Med. 201: 1925-1935. (Pubitemid 41002929)
48. Wood, K. J., G. Feng, B. Wei, B. Sawitzki, and A. R. Bushell. 2007. Interferon gamma: friend or foe? Transplantation 84(Suppl): S4-S5. (Pubitemid 47067533)
49. Vercoulen, Y., E. J. Wehrens, N. H. van Teijlingen, W. de Jager, J. M. Beekman, and B. J. Prakken. 2009. Human regulatory T cell suppressive function is independent of apoptosis induction in activated effector T cells. PLoS ONE 4: e7183.
50. Shevach, E. M. 2009. Mechanisms of foxp3+ T regulatory cell-mediated suppression. Immunity 30: 636-645.
51. Scott, D., C. Addey, P. Ellis, E. James, M. J. Mitchell, N. Saut, S. Jurcevic, and E. Simpson. 2000. Dendritic cells permit identification of genes encoding MHC class II-restricted epitopes of transplantation antigens. Immunity 12: 711-720.
52. Hambach, L., Z. Aghai, J. Pool, N. Kröger, and E. Goulmy. 2010. Peptide length extension skews the minor HA-1 antigen presentation toward activated dendritic cells but reduces its presentation efficiency. J. Immunol. 185: 4582- 4589.